Production (Stage)
Xilio Therapeutics, Inc.
XLO
$0.8838
-$0.0132-1.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.10% | -9.74% | -18.27% | 120.57% | -23.99% |
| Total Receivables | 0.00% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.73% | 43.56% | -32.98% | -41.23% | 52.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 54.73% | -4.86% | -18.84% | 12.75% | 43.76% |
|
|
|||||
| Total Current Assets | 54.73% | -4.86% | -18.84% | 12.75% | 43.76% |
| Net Property, Plant & Equipment | -3.65% | -5.38% | -4.30% | -5.09% | -5.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.34% | 0.39% | -4.62% | -35.47% | 80.48% |
| Total Assets | 45.92% | -4.80% | -16.93% | 8.79% | 35.59% |
|
|
|||||
| Total Accounts Payable | -11.62% | 164.81% | -23.10% | 69.44% | -28.95% |
| Total Accrued Expenses | -61.10% | 1.92% | 0.58% | 21.68% | -23.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.20% | 3.13% | 2.58% | 1.26% | -74.85% |
| Total Finance Division Other Current Liabilities | 197.77% | -48.22% | -1.55% | 22.06% | -- |
| Total Other Current Liabilities | 197.77% | -48.22% | -1.55% | 22.06% | -- |
| Total Current Liabilities | 74.74% | -28.30% | -1.60% | 22.35% | 97.92% |
|
|
|||||
| Total Current Liabilities | 74.74% | -28.30% | -1.60% | 22.35% | 97.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.54% | -4.25% | -4.00% | -3.78% | -3.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 101.13% | 129.34% | -18.06% | -41.09% | -- |
| Total Liabilities | 73.94% | -0.39% | -4.91% | -0.68% | 135.88% |
|
|
|||||
| Common Stock & APIC | 1.59% | 2.48% | 0.40% | 5.86% | 1.69% |
| Retained Earnings | -3.46% | -3.53% | -3.93% | -4.06% | -5.28% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -39.20% | -16.10% | -37.23% | 29.70% | -30.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.20% | -16.10% | -37.23% | 29.70% | -30.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.20% | -16.10% | -37.23% | 29.70% | -30.04% |
|
|
|||||